Freestone Grove Partners’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67.6M Sell
162,682
-18,229
-10% -$6.76M 0.43% 56
2026
Q1
$49M Sell
180,911
-26,449
-13% -$7.88M 0.35% 93
2025
Q4
$68.5M Buy
+207,360
New +$70.3M 0.49% 42
2025
Q2
Sell
-66,315
Closed -$34.7M 862
2025
Q1
$34.7M Sell
66,315
-30,330
-31% -$15.5M 0.36% 94
2024
Q4
$48.9M Buy
+96,645
New +$54.9M 0.6% 50

Other funds holding UNH

Freestone Grove Partners's UNH Position: Q2 2026 in Review

Freestone Grove Partners reduced its UnitedHealth (UNH) stake by 10% in Q2 2026, selling an estimated $6.76M and leaving 162,682 shares worth $67.6M. The position accounts for 0.43% of the portfolio, ranked #56.

Freestone Grove Partners first reported a position in UNH in Q4 2024 and has held it in 5 quarters since. The position peaked at $68.5M in Q4 2025. 3,378 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Freestone Grove Partners held 162,682 shares of UnitedHealth worth $67.6M as of Q2 2026.
  • Freestone Grove Partners sold 18,229 UnitedHealth shares in Q2 2026, an estimated $6.76M.
  • UnitedHealth made up 0.43% of Freestone Grove Partners's portfolio in Q2 2026, its #56 holding.
  • Freestone Grove Partners first reported a position in UnitedHealth in Q4 2024 and has held it in 5 quarters since.
  • Freestone Grove Partners's UnitedHealth position peaked at $68.5M in Q4 2025.
  • 3,378 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.